Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to Monotherapy

NCT01628601 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT01628601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01628601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to Monotherapy
Lead sponsor
Allergan
Phase
Observational
Overall status
Completed
Start date
May 31, 2010
Completion date
June 30, 2011
Enrollment
392 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, open-angle, ocular hypertension